A citation-based method for searching scientific literature

Adam E Snook, Michael S Magee, Glen P Marszalowicz, Stephanie Schulz, Scott A Waldman. Cancer Immunol Immunother 2012
Times Cited: 15







List of co-cited articles
63 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
Adam E Snook, Benjamin J Stafford, Peng Li, Gene Tan, Lan Huang, Ruth Birbe, Stephanie Schulz, Matthias J Schnell, Mathew Thakur, Jay L Rothstein,[...]. J Natl Cancer Inst 2008
41
80

Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.
Adam E Snook, Peng Li, Benjamin J Stafford, Elizabeth J Faul, Lan Huang, Ruth C Birbe, Alessandro Bombonati, Stephanie Schulz, Matthias J Schnell, Laurence C Eisenlohr,[...]. Cancer Res 2009
32
73

Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
Adam E Snook, Michael S Magee, Stephanie Schulz, Scott A Waldman. Eur J Immunol 2014
32
60

Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
A E Snook, L C Eisenlohr, J L Rothstein, S A Waldman. Clin Pharmacol Ther 2007
23
53

Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
S L Carrithers, M T Barber, S Biswas, S J Parkinson, P K Park, S D Goldstein, S A Waldman. Proc Natl Acad Sci U S A 1996
182
46

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
Glen P Marszalowicz, Adam E Snook, Michael S Magee, Dante Merlino, Lisa D Berman-Booty, Scott A Waldman. Oncotarget 2014
20
46

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
Michael S Magee, Crystal L Kraft, Tara S Abraham, Trevor R Baybutt, Glen P Marszalowicz, Peng Li, Scott A Waldman, Adam E Snook. Oncoimmunology 2016
45
46

Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.
Bo Xiang, Trevor R Baybutt, Lisa Berman-Booty, Michael S Magee, Scott A Waldman, Vitali Y Alexeev, Adam E Snook. J Immunol 2017
24
46

Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Ruth Birbe, Juan P Palazzo, Rhonda Walters, David Weinberg, Stephanie Schulz, Scott A Waldman. Hum Pathol 2005
97
40


Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
Scott A Waldman, Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, David S Weinberg. JAMA 2009
87
33

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Michael A Valentino, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman. J Clin Invest 2011
109
33

Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.
Matthew Witek, Erik S Blomain, Michael S Magee, Bo Xiang, Scott A Waldman, Adam E Snook. Int J Radiat Oncol Biol Phys 2014
17
33

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.
Adam E Snook, Trevor R Baybutt, Bo Xiang, Tara S Abraham, John C Flickinger, Terry Hyslop, Tingting Zhan, Walter K Kraft, Takami Sato, Scott A Waldman. J Immunother Cancer 2019
29
33

Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens.
Adam E Snook, Lan Huang, Stephanie Schulz, Laurence C Eisenlohr, Scott A Waldman. Clin Transl Sci 2008
7
57

Escherichia coli heat-stable toxin receptors in human colonic tumors.
S L Carrithers, S J Parkinson, S Goldstein, P Park, D C Robertson, S A Waldman. Gastroenterology 1994
80
26

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
98
26

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Glen S Frick, Giovanni M Pitari, David S Weinberg, Terry Hyslop, Stephanie Schulz, Scott A Waldman. Expert Rev Mol Diagn 2005
51
26

Guanylyl cyclases and signaling by cyclic GMP.
K A Lucas, G M Pitari, S Kazerounian, I Ruiz-Stewart, J Park, S Schulz, K P Chepenik, S A Waldman. Pharmacol Rev 2000
914
26

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Philip W Kantoff, Celestia S Higano, Neal D Shore, E Roy Berger, Eric J Small, David F Penson, Charles H Redfern, Anna C Ferrari, Robert Dreicer, Robert B Sims,[...]. N Engl J Med 2010
26

Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases.
Michael S Magee, Tara S Abraham, Trevor R Baybutt, John C Flickinger, Natalie A Ridge, Glen P Marszalowicz, Priyanka Prajapati, Adam R Hersperger, Scott A Waldman, Adam E Snook. Cancer Immunol Res 2018
66
26

Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
Jason Park, Stephanie Schulz, Janis Haaf, John C Kairys, Scott A Waldman. Cancer Epidemiol Biomarkers Prev 2002
29
20

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
20

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Stephanie Schulz, Terry Hyslop, Janis Haaf, Christine Bonaccorso, Karl Nielsen, Matthew E Witek, Ruth Birbe, Juan Palazzo, David Weinberg, Scott A Waldman. Clin Cancer Res 2006
64
20

Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior.
Rong Gong, Cheng Ding, Ji Hu, Yao Lu, Fei Liu, Elizabeth Mann, Fuqiang Xu, Mitchell B Cohen, Minmin Luo. Science 2011
77
20

Breakthrough of the year 2013. Cancer immunotherapy.
Jennifer Couzin-Frankel. Science 2013
20

TCR Retrogenic Mice as a Model To Map Self-Tolerance Mechanisms to the Cancer Mucosa Antigen GUCY2C.
Tara S Abraham, John C Flickinger, Scott A Waldman, Adam E Snook. J Immunol 2019
5
60

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
John C Flickinger, Jagmohan Singh, Robert Carlson, Elinor Leong, Trevor R Baybutt, Joshua Barton, Ellen Caparosa, Amanda Pattison, Jeffrey A Rappaport, Jamin Roh,[...]. J Immunother Cancer 2020
12
25

Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors.
S L Carrithers, S J Parkinson, S D Goldstein, P K Park, R W Urbanski, S A Waldman. Dis Colon Rectum 1996
61
13

The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.
Matthew E Witek, Karl Nielsen, Rhonda Walters, Terry Hyslop, Juan Palazzo, Stephanie Schulz, Scott A Waldman. Clin Cancer Res 2005
71
13

T-cell response to adenovirus hexon and DNA-binding protein in mice.
T McKelvey, A Tang, A J Bett, D R Casimiro, M Chastain. Gene Ther 2004
32
13

CTLA-4 control over Foxp3+ regulatory T cell function.
Kajsa Wing, Yasushi Onishi, Paz Prieto-Martin, Tomoyuki Yamaguchi, Makoto Miyara, Zoltan Fehervari, Takashi Nomura, Shimon Sakaguchi. Science 2008
13

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.
J Alexander, J Sidney, S Southwood, J Ruppert, C Oseroff, A Maewal, K Snoke, H M Serra, R T Kubo, A Sette. Immunity 1994
418
13

Cancer immunotherapy comes of age.
Ira Mellman, George Coukos, Glenn Dranoff. Nature 2011
13

Monogenic autoimmunity.
Mickie H Cheng, Mark S Anderson. Annu Rev Immunol 2012
60
13

DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection.
Andrea Facciabene, Luigi Aurisicchio, Leonardo Elia, Fabio Palombo, Carmela Mennuni, Gennaro Ciliberto, Nicola La Monica. Hum Gene Ther 2006
35
13

The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate.
Daniela Santoro Rosa, Fanny Tzelepis, Maristela G Cunha, Irene S Soares, Mauricio M Rodrigues. Immunol Lett 2004
39
13

Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Stephen L Carrithers, Cobern E Ott, Michael J Hill, Brett R Johnson, Weiyan Cai, Jason J Chang, Rajesh G Shah, Congmei Sun, Elizabeth A Mann, Manasses C Fonteles,[...]. Kidney Int 2004
73
13

DNA vaccines: developing new strategies against cancer.
Daniela Fioretti, Sandra Iurescia, Vito Michele Fazio, Monica Rinaldi. J Biomed Biotechnol 2010
119
13

PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
13

Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
Dung T Le, Andrea Wang-Gillam, Vincent Picozzi, Tim F Greten, Todd Crocenzi, Gregory Springett, Michael Morse, Herbert Zeh, Deirdre Cohen, Robert L Fine,[...]. J Clin Oncol 2015
372
13


Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.
John G Facciponte, Stefano Ugel, Francesco De Sanctis, Chunsheng Li, Liping Wang, Gautham Nair, Sandy Sehgal, Arjun Raj, Efthymia Matthaiou, George Coukos,[...]. J Clin Invest 2014
54
13

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.
Shyra J Gardai, Kathleen A McPhillips, S Courtney Frasch, William J Janssen, Anna Starefeldt, Joanne E Murphy-Ullrich, Donna L Bratton, Per-Arne Oldenborg, Marek Michalak, Peter M Henson. Cell 2005
970
13

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.
Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, John M Abrams, Dieter Adam, Patrizia Agostinis, Emad S Alnemri, Lucia Altucci, Ivano Amelio, David W Andrews,[...]. Cell Death Differ 2018
13

Immunogenic cell death in cancer and infectious disease.
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel, Guido Kroemer. Nat Rev Immunol 2017
13

Human Tumor Antigens and Cancer Immunotherapy.
Nathalie Vigneron. Biomed Res Int 2015
112
13

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.
Mahesh Yadav, Suchit Jhunjhunwala, Qui T Phung, Patrick Lupardus, Joshua Tanguay, Stephanie Bumbaca, Christian Franci, Tommy K Cheung, Jens Fritsche, Toni Weinschenk,[...]. Nature 2014
746
13

Neoantigens in cancer immunotherapy.
Ton N Schumacher, Robert D Schreiber. Science 2015
13

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.
Michael Kalos, Bruce L Levine, David L Porter, Sharyn Katz, Stephan A Grupp, Adam Bagg, Carl H June. Sci Transl Med 2011
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.